Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

epelsiban MeSH Supplementary Concept Data 2025


MeSH Supplementary
epelsiban
Unique ID
C571185
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C571185
Entry Term(s)
3-(2,3-dihydro-1H-inden-2-yl)-1-(1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl)-6-(1-methylpropyl)-2,5-piperazinedione
GSK557296
Registry Numbers
T2EZ19HX73
0
CAS Type 1 Name
(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2,6- dimethylpyridin-3-yl)-2-(morpholin- 4-yl)-2-oxoethyl)-6- ((1S)-1-methylpropyl)piperazine-2,5-dione
Heading Mapped to
*Morpholines
*Diketopiperazines
Frequency
6
Note
structure in first source
Source
J Med Chem. 2012 Jan 26;55(2):783-96.
Date of Entry
2012/04/08
Revision Date
2014/10/20
epelsiban Preferred
3-(2,3-dihydro-1H-inden-2-yl)-1-(1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl)-6-(1-methylpropyl)-2,5-piperazinedione Broader
GSK557296 Narrower
page delivered in 0.002s